Search - tctmd.com

Displaying 661 - 680 of 696

Sort: Relevancy | Date

News Conference News TCT 2012

Pulmonary Artery Denervation Effective for PAH

October 24, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

October 16, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

October 16, 2012

News Industry News

Medtronic Announces First Patient Enrollment in Global Heart Rhythm Study

September 20, 2012

News Conference News ESC 2012

Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit

Yael L. Maxwell

August 29, 2012

News Conference News ESC 2012

Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming

Caitlin E. Cox

August 26, 2012

News Daily News

Meta-analysis: Transradial Access Cheaper, Safer for Coronary Procedures

Yael L. Maxwell

July 13, 2012

News Daily News

Meta Análisis: El Abordaje Transradial es Más Barato y Seguro para las Intervenciones Coronarias

Yael L. Maxwell

July 13, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Caitlin E. Cox

May 18, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

News Industry News

Medtronic Expands Availability of Valiant® Captivia® Stent Graft in Major Global Markets

May 08, 2012

News Industry News

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

April 09, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

L.A. McKeown

March 26, 2012

News Daily News

El Tratamiento con Células Madre Cardíacas es Seguro y Podría Regenerar el Tejido Cardíaco

Caitlin E. Cox

March 06, 2012

News Daily News

Cardiac Stem Cell Therapy Safe, May Regenerate Heart Tissue

Caitlin E. Cox

March 06, 2012

News Industry News

St. Jude Medical Initiates a Study to Evaluate the Economic Impact of FFR in Asia and Australia

February 14, 2012

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Conference News

Safety, Efficacy Reported with FIREHAWK SES

November 08, 2011

Advertisement

Pulmonary Artery Denervation Effective for PAH

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

Medtronic Announces First Patient Enrollment in Global Heart Rhythm Study

Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit

Niacin Holds No Surprise Side Effects But Efficacy Data Forthcoming

Meta-analysis: Transradial Access Cheaper, Safer for Coronary Procedures

Meta Análisis: El Abordaje Transradial es Más Barato y Seguro para las Intervenciones Coronarias

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Medtronic Expands Availability of Valiant® Captivia® Stent Graft in Major Global Markets

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

El Tratamiento con Células Madre Cardíacas es Seguro y Podría Regenerar el Tejido Cardíaco

Cardiac Stem Cell Therapy Safe, May Regenerate Heart Tissue

St. Jude Medical Initiates a Study to Evaluate the Economic Impact of FFR in Asia and Australia

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Safety, Efficacy Reported with FIREHAWK SES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content